XGEVA® (Denosumab) is a sterile, preservative-free solution for subcutaneous injection, engineered for precise therapeutic delivery. Each single-dose vial provides 120 mg of denosumab formulated in 1.7 mL of solution (70 mg/mL). Developed through a strategic collaboration between Amgen and Dr. Reddy’s, this advanced biologic therapy is designed to inhibit specific bone-resorbing proteins, helping to prevent skeletal-related events and manage serious bone conditions. To ensure efficacy and patient safety, the medication must be stored according to professional guidelines and administered strictly by a healthcare professional. Keep out of reach of children.